Reprint
Breast Cancer Imaging and Therapy
Edited by
June 2023
228 pages
- ISBN978-3-0365-7930-6 (Hardback)
- ISBN978-3-0365-7931-3 (PDF)
This book is a reprint of the Special Issue Breast Cancer Imaging and Therapy that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
In Canada, survival from breast cancer has steadily increased since 1989, and breast cancer mortality has decreased by 48%. While 82% of women with breast cancer are diagnosed at stage 1 or 2, there are still 18% who present at a late stage and 25% who develop metastatic disease. Improved survival has been achieved through early diagnosis of breast cancer with screening, allowing for more effective and targeted treatments. This reprint summarizes the latest evidence on the early detection of breast cancer and highlights areas where this may be improved.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
contrast-enhanced spectral mammography; breast cancer; neoadjuvant chemotherapy; complete response; response evaluation criteria in solid tumors; contrast-enhanced mammography; magnetic resonance imaging; image enhancement; contrast media; radiomics; artificial intelligence; breast; cancer; screening; dense; patient advocacy; breast density; breast density notification; Canada; mammography; breast ultrasound; breast density; breast cancer screening; interval cancer; mortality reduction; breast MRI; digital breast tomosynthesis; molecular breast imaging; contrast-enhanced mammography; breast cancer screening; breast cancer; overdetection; Canadian National Breast Screening Study; overdiagnosis; overtreatment; microsimulation; mammography; mammographic screening; randomization; expertise; guidelines; evidenc; epistemic trespassing; evidence-based medicine; breast cancer; risk factors; screening mammography; knowledge assessment; barriers; questionnaire examination; DBT; ultrasound; benign biopsy; breast density; breast cancer; breast cancer; screening mammography; stage shift; registries; prevention; recommendations; clinical practice; breast; cancer; screening; breast screening; high-risk breast screening; dense breasts; supplemental breast screening; breast MRI; breast cancer; cardiovascular disease; chemotherapy; radiotherapy; mortality; breast cancer; adjuvant endocrine therapy; adherence to treatment; side effects; tamoxifen; aromatase inhibitors; GnRH agonist; questionnaire; n/a